glutathione stransferase deficiency Overexpression of S-Transferases in Human Diseases: Drug Targets and Therapeutic Implications Modulation of Glutathione-S-Transferase by Phytochemicals:

In other words, there was no universally accepted chemical formula for each peptide, making it extremely difficult for the FDA to evaluate its use

Conditions such as kidney impairment, Lebers disease, and folate deficiency influence how it is used and monitored

The molecular docking and dynamics studies revealed that DSF formed a stable complex with PIK3 via interactions with residues Ile932, Ile800, Ile848, Met772, and Trp780, which contributed significantly to stability

particularly, there is a reordering of six residues at the C-terminus of the large subunit with suggested role in enzyme catalysis (Lin et al., 2014)

[DOI] [PMC free article] [PubMed] [Google Scholar] 148.Kreppel H., Liu J., Liu Y., Reichl F.X., Klaassen C.D